Hovnanian Enterprises, Inc. (HOV)
NYSE: HOV · Real-Time Price · USD
133.23
+1.05 (0.79%)
Aug 8, 2025, 4:00 PM - Market closed

Achilles Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Sell
Price Target
$120.00
Upside
-9.93%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wedbush
Wedbush
Hold
Reiterates
$120
HoldReiterates$120-9.93%Jun 11, 2025
Wedbush
Wedbush
Hold
Maintains
$155$120
HoldMaintains$155$120-9.93%Feb 25, 2025
Zelman & Assoc
Zelman & Assoc
Sell
Downgrades
n/a
SellDowngradesn/an/aFeb 12, 2025
Wedbush
Wedbush
Hold
Initiates
$155
HoldInitiates$155+16.34%Dec 16, 2024
Zelman & Assoc
Zelman & Assoc
Hold
Upgrades
$155
HoldUpgrades$155+16.34%May 23, 2024
JMP Securities
JMP Securities
Hold
Upgrades
n/a
HoldUpgradesn/an/aOct 9, 2018
MKM Partners
MKM Partners
Strong Sell
Downgrades
n/a
Strong SellDowngradesn/an/aDec 22, 2017
JMP Securities
JMP Securities
Sell
Downgrades
n/a
SellDowngradesn/an/aJan 12, 2017
JMP Securities
JMP Securities
Hold
Upgrades
n/a
HoldUpgradesn/an/aJun 10, 2015
MKM Partners
MKM Partners
Hold
Maintains
$100$75
HoldMaintains$100$75-43.71%Jun 10, 2015
JMP Securities
JMP Securities
Sell
Downgrades
$100$75
SellDowngrades$100$75-43.71%Jan 20, 2015
JMP Securities
JMP Securities
Hold
Upgrades
$100
HoldUpgrades$100-24.94%Oct 22, 2014